Aspire Biopharma Holdings, Inc. (ASBP) vs IM Cannabis Corp. (IMCC)
A side-by-side comparison of Aspire Biopharma Holdings, Inc. and IM Cannabis Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASBP
Aspire Biopharma Holdings, Inc.
$8.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
IMCC
IM Cannabis Corp.
$1.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ASBP vs IMCC
growth of $100 · dividends reinvested · last 4yASBP -99.9% (-83.5%/yr)IMCC -100.0% (-85.1%/yr)ASBP compounded faster over this window
ASBP IMCC
ASBP vs IMCC: by the numbers
- •IMCC is the larger company ($1M vs $1M market cap).
- •Both run net losses; IMCC's is the smaller (-38.08% vs -11314.24% net margin).
Metrics side by side
Valuation
| Metric | ASBP | IMCC |
|---|---|---|
| P/S ratio | 10.35 | 0.04 |
| P/B ratio | 0.09 | N/A |
Profitability
| Metric | ASBP | IMCC |
|---|---|---|
| Gross margin | -1.87% | 13.74% |
| Operating margin | -312016.95% | -25.95% |
| Net margin | -11314.24% | -38.08% |
| ROE | -93.97% | N/A |
| ROIC | -59.81% | -128.95% |
Growth (annualized)
| Metric | ASBP | IMCC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 4.19% |
| Total return CAGR (5Y) | N/A | -80.08% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.